Skip to main content

Translational research in the new decade: Rheumatology at the forefront

28th, February 2020 | Vienna General Hospital, Hörsaalzentrum, 7th floor

Welcome

Advances in the field of systems biology have increased our understanding of the mechanisms that drive autoimmunity and inflammation and led to the development of novel therapies and therapeutic strategies, such as Janus-kinase inhibitors and precision medicine approaches. In parallel, better characterization of the complexity of clinical manifestations have increased our understanding of the sophistications of common as well as rare disease.

Future challenges will be to integrate big data derived from omics with clinical data to foster the development of stratified therapies in rheumatology and beyond.  Novel techniques such as deep learning, will help to predict disease courses and treatment responses in order to tailor treatment towards maximizing therapeutic effects and minimizing adverse events. Future studies will aim to translate molecular knowledge into clinical applications and ultimately to prevent the development of autoimmune diseases.

These and other important aspects wil be addressed in this symposium.

Josef Smolen & Michael Bonelli


Programme

14.00 | Welcome

  • Markus Müller
    Rektor of the Medical University of Vienna
  • Michael Bonelli & Josef Smolen
    Medical University of Vienna

14.15 | Session I

Chairs: Alexandra Kautzky-Willer and Michael Trauner, Vienna

  • 14.15 – 14.45
    Systems approaches to autoimmune diseases
    Giulio Superti-Furga, Vienna
  • 14.45 – 15.15
    Spearheading precision medicine in rheumatology: The expanding spectrum of autoinflammatory diseases
    Raphaela Goldbach-Mansky, Bethesda
  • 15.15 – 15.45
    Advances in the treatment of systemic sclerosis –
    is there hope?

    Oliver Distler, Zurich
  • 15.45 – 16.15
    Multimorbidity as a challenge in rheumatology?
    Dan Solomon, Boston

16.15 | Coffee Break

16.40 | Session II

Chairs: Ursula Wiedermann-Schmidt and Rainer Oberbauer, Vienna

  • 16.40 – 17.10
    Bones of contention: Controversies in rheumatic diseases and bone
    Ellen Gravallese, Boston
  • 17.10 – 17.40
    Infections and other complications of JAK inhibition: how best to prevent them
    Kevin Winthrop, Portland
  • 17.40 – 18.10
    Genomic views of cytokine signaling and lymphocyte differentiation
    John O’Shea, NIH, Bethesda

18.10 | Final remarks

  • Daniel Aletaha, Vienna

John O’Shea Scientific Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, USA

Raphaela Goldbach-Mansky Chief, Translational Autoinflammatory Disease Studies Unit, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA

Daniel Solomon Chief, Section of Clinical Sciences, Division of Rheumatology, Brigham and Women’s
Hospital, Harvard Medical School, Boston, MA, USA; Editor, Arthritis and Rheumatology

Ellen Gravallese Chief, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA; President, American College of Rheumatology;
Associate Editor, New England Journal of Medicine

Giulio Superti-Furga Scientific Director, Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

Kevin Winthrop Director, Center for Infectious Disease Studies, Oregon Health & Science University, Portland, OR, USA

Oliver Distler Director, Department of Rheumatology, University Hospital Zürich, Switzerland

Daniel Aletaha Head, Division of Rheumatology, Medical University of Vienna/ Vienna General Hospital; Treasurer, European League Against Rheumatism 

Alexandra Kautzky-Willer Head, Departmentment of Medicine III, Medical University of Vienna/ Vienna General Hospital

Michael Trauner Head, Divison of Gastroentereology and Hepatology, Medical University of Vienna/ Vienna General Hospital

Ursula Wiedermann-Schmidt Head, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna

Rainer Oberbauer Head, Division of Nephrology and Dialysis, Medical University of Vienna/ Vienna General Hospital

Organized by

Michael Bonelli Division of Rheumatology, Medical University of Vienna/Vienna General Hospital

Josef Smolen em. Professor of Rheumatology, Medical University of Vienna; Editor, Annals of the Rheumatic Diseases

Admission is free. Please register here:

Your data will only be used to process your participation in the event and will be deleted after the storage period has expired in accordance with the  GDPR. » Further information.

Please note: During the event, photos and videos will be produced on behalf of the Medical University of Vienna for public relations purposes.

Inaugural Lecture of Daniel Aletaha Please also note the Inaugural Lecture of Daniel Aletaha as Professor of Rheumatology at the Medical University of Vienna, starting at 11.30 at the same venue. Info